# Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lupus-low-disease-activity-state-lldas-discriminates-responders-in-the-bliss-52/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shereen Oon,Molla Huq,Vera Golder,Pei Xuan Ong,Eric F. Morand,Mandana Nikpour |
| Citations | 91 |
| DOI | 10.1136/annrheumdis-2018-214427 |
| Fields | Medicine,Neuroscience |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2912932678 |
| PMID | 30679152 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Vera Golder](https://scholariq.org/researchers/vera-golder/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Vagus Nerve Stimulation Research](https://scholariq.org/topics/vagus-nerve-stimulation-research/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.